Tsakos.jpg
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
May 08, 2024 16:05 ET | Tsakos Energy Navigation
ATHENS, Greece, May 08, 2024 (GLOBE NEWSWIRE) -- TEN Ltd. (“TEN”) (NYSE: TNP) (the “Company”), a leading diversified crude, product and LNG tanker operator, today announced that its Board of...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces First Quarter 2024 Financial Results
May 08, 2024 16:05 ET | electroCore, Inc.
Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023Company to host a conference call and webcast today, May 8, 2024 at 4:30 PM EST ROCKAWAY, N.J., May 08,...
Surrozen Logo FINAL Large-1.png
Surrozen Provides First Quarter 2024 Financial Results and Business Update
May 08, 2024 16:05 ET | Surrozen, Inc.
Surrozen Provides First Quarter 2024 Financial Results and Business Update
NPCE Logo.png
NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 08, 2024 16:05 ET | NeuroPace, Inc
-- Revenue increased to $18.1 million in Q1 2024, a 25% increase over Q1 2023 -- -- Extended the maturity date of the Company’s term loan by one year to September 30, 2026 -- -- Maintained full-year...
Pathfinder Bancorp, Inc..jpg
Pathfinder Bancorp, Inc. Announces the Retirement of Chief Financial Officer and Names Successor
May 08, 2024 16:05 ET | Pathfinder Bancorp, Inc.
OSWEGO, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- Pathfinder Bancorp, Inc. (“Pathfinder”) (NASDAQ: PBHC) today announced that Walter F. Rusnak, CPA, 70, Senior Vice President and Chief Financial...
AssemblyBio_logo_RGB.png
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
May 08, 2024 16:05 ET | Assembly Biosciences, Inc.
Clinical trial application clearances received for a Phase 1a/1b trial for ABI-5366 targeting recurrent genital herpes, and a Phase 1b trial for ABI-4334 in chronic HBV infection; both studies on...
tarsus-logo-stacked-color-532x626.png
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
May 08, 2024 16:05 ET | Tarsus Pharmaceuticals, Inc
Generated $24.7 million in net product sales of XDEMVY®, an 89% increase over Q4 2023, and delivered approximately 26,000 bottles of XDEMVY to patients Secured multiple commercial payer contracts and...
RH_Logo_RGB_Green_101019.png
Robinhood Reports First Quarter 2024 Results
May 08, 2024 16:05 ET | Robinhood Markets, Inc.
Record Revenues of $618 million, up 40% year-over-year and Record GAAP Diluted EPS of $0.18 Record Net Deposits of $11.2B, including net positive transfers from every major incumbent brokerage firm ...
terns-color.png
Terns Pharmaceuticals Announces Leadership Changes
May 08, 2024 16:05 ET | Terns Pharmaceuticals, Inc.
FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
dave_logo_2022@4x (1).png
Dave to Participate in Upcoming Investor Conferences in May
May 08, 2024 16:05 ET | Dave Operating LLC
LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- Dave Inc. (“Dave” or the “Company”) (Nasdaq: DAVE), one of the nation’s leading neobanks, today announced that the Company will participate in two...